Biological medicines

PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection

When patients with non-myeloid malignancies receive antitumor therapy that inhibits bone marrow with clinically meaningful febrile neutropenia, this drug reduces the incidence of infections caused by febrile neutropenia。 This product is not used for mobilization of peripheral blood progenitor cells from hematopoietic stem cell transplantation。


懂彩帝彩票平台 好博彩票平台 鑫乐博彩票平台 大都会彩票平台 百易彩票平台 彩拾彩票平台 易投彩票平台 928彩票平台 易中彩票平台 彩票平台33